| SOPHIA GENETICS SF -,05 |
| Schweiz |
| Gesundheit |
| CH1125843347 / A3CVT8 |
| 90B (Frankfurt) / SOPH (NASDAQ) |
| FRA:90B, ETR:90B, 90B:GR, NASDAQ:SOPH |
| - |
| https://www.sophiagenetic.. |
|
SOPHiA GENETICS SA Ordinary Shares is the equity of SOPHiA GENETICS, a healthcare technology company focused on data-driven medicine and life sciences research. The company develops cloud-native software that analyzes complex genomic and multimodal h..
>Volltext.. |
| 558.09 Mio. EUR |
| 517.37 Mio. EUR |
| 76.54 Mio. EUR |
| -55.2 Mio. EUR |
| -71.85 Mio. EUR |
| -1.02 EUR |
| 54.92 Mio. EUR |
| 95.64 Mio. EUR |
| -39.3 Mio. EUR |
| 2.11 |
| 23.65% |
| -10.2% |
| - |
| - |
| - |
| SOPHIA GENETICS, SOPHIA GENETIC |
| 07.10.26 |
|
||||
|